Login

Ownership

Who owns EUPRAXIA PHARMACEUTICALS INC., from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).

Stakes over 5%

Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.

MANCHESTER MANAGEMENT COMPANY, LLC, MANCHESTER MANAGEMENT PR, LLC, MANCHESTER EXPLORER, L.P. August 13, 2026

MANCHESTER MANAGEMENT COMPANY, LLC: 4.3% · 2,634,048 shares — MANCHESTER MANAGEMENT PR, LLC: 4.3% · 2,634,048 shares — MANCHESTER EXPLORER, L.P.: 4.1% · 2,511,121 shares

Joseph S. Freedman March 16, 2026

Joseph S. Freedman: 9.0% · 5,843,215 shares

4 more 5% stakes behind a free account

See every investor who has disclosed crossing 5% of EUPRAXIA PHARMACEUTICALS INC..

Sign up free

Super investors holding EPRX

Every institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of EUPRAXIA PHARMACEUTICALS INC. they hold.

Investor Position value Shares % of their portfolio % of company As of
Beutel, Goodman & Co Ltd. $23.8M 3,627,864 0.18% June 30, 2026
Affinity Asset Advisors, LLC $10.9M 1,650,000 0.49% June 30, 2026

73 more institutional holders behind a free account

See every manager reporting EUPRAXIA PHARMACEUTICALS INC., how much of the company they hold, and how big the position is inside their own portfolio.

Sign up free

Funds holding EPRX

Funds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets.

Fund Position value % of net assets % of company As of
Fidelity Nasdaq Composite Index Fund $146K 0.00% February 28, 2026
Blackstone Alternative Multi-Strategy Fund $1.98K 0.00% June 30, 2026

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support